Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

5.63
Delayed Data
As of Aug 21
 -0.05 / -0.88%
Today’s Change
2.73
Today|||52-Week Range
11.19
+6.63%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close5.68
Today’s open5.61
Day’s range5.61 - 5.65
Volume5,176
Average volume (3 months)159,239
Market cap$90.4M
Dividend yield--
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)+18.67%
Earnings growth (this year)+4.92%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.51

Competitors

 Today’s
change
Today’s
% change
--China Health Group I...0.000.00%
CRMECardiome Pharma Corp-1.27-32.82%
NTECIntec Pharma Ltd+0.60+9.76%
RGLSRegulus Therapeutics...+0.02+2.46%
Data as of 08/22/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$17.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts